Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital: Evidence from a Cross-Sectional Study

Ahlawat, Rajiv; Tiwari, Pramil; D’Cruz, Sanjay

doi:10.1016/j.vhri.2016.10.003

Cited by 14 publications

(22 citation statements)

References 20 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…After comparing our costs with the results in other countries, a large variation in costs was observed. The average hospitalization cost (CNY15,517.7=$2,458.2) in this study was much lower than that was found in the USA ($39,873, 2014 price) (Ozieh et al , 2017) and European countries, €4,300 (2009 price) in Sweden (Eriksson et al , 2016), €3,912.8 (2011 price) in Italy (Roggeri et al , 2017), but much higher than that in other Asia countries, such as $386 in India (Ahlawat et al , 2017). The international comparison of medical costs for CKD patients was limited by different data sources (survey data or claims data) and different health services (outpatient or inpatient care), but the variation in costs was mainly attributable to the varied healthcare systems across different countries.…”

Section: Discussioncontrasting

confidence: 66%

See 1 more Smart Citation

Costs of hospitalization for chronic kidney disease in Guangzhou, China

Zhang

Zhu

et al. 2019

PAP

View full text Add to dashboard Cite

Purpose Chronic kidney disease (CKD) is a worldwide public health problem which imposes a significant financial burden not only on patients but also on the healthcare systems, especially under the pressure of the rapid growth of the elderly population in China. The purpose of this paper is to examine the hospitalization costs of patients with CKD between two urban health insurance schemes and investigate the factors that were associated with their inpatient costs in Guangzhou, China. Design/methodology/approach This was a prevalence-based, observational study using data derived from two insurance claims databases during the period from January 2010 to December 2012 in the largest city, Guangzhou in Southern China. The authors identified 5,803 hospitalizations under two urban health insurance schemes. An extension of generalized linear model – the extended estimating equations approach – was performed to identify the main drivers of total inpatient costs. Findings Among 5,803 inpatients with CKD, the mean age was 60.6. The average length of stay (LOS) was 14.4 days. The average hospitalization costs per inpatient were CNY15,517.7. The mean inpatient costs for patients with Urban Employee-based Basic Medical Insurance (UEBMI) scheme (CNY15,582.0) were higher than those under Urban Resident-based Basic Medical Insurance (URBMI) scheme (CNY14,917.0). However, the percentage of out-of-pocket expenses for the UEBMI patients (19.8 percent) was only half of that for the URBMI patients (44.5 percent). Insurance type, age, comorbidities, dialysis therapies, severity of disease, LOS and hospital levels were significantly associated with hospitalization costs. Originality/value The costs of hospitalization for CKD were high and differed by types of insurance schemes. This was the first study to compare the differences in hospitalization costs of patients with CKD under two different urban insurance schemes in China. The findings of this study could provide economic evidence for understanding the burden of CKD and evaluating different treatment of CKD (dialysis therapy) in China. Such useful information could also be used by policy makers in health insurance program evaluation and health resources allocation.

show abstract

Section: Discussioncontrasting

confidence: 66%

“…Many countries have evaluated the economic burden and direct medical costs of CKD (Ahlawat et al , 2017; Eriksson et al , 2016; Kim et al , 2017; Ozieh et al , 2017; Roggeri et al , 2017). However, only one study examined the hospitalization costs of CKD in China (Liang et al , 2016).…”

Section: Introductionmentioning

confidence: 99%

Costs of hospitalization for chronic kidney disease in Guangzhou, China

Zhang

Zhu

et al. 2019

PAP

View full text Add to dashboard Cite

show abstract

“…Treatment cost was found to be significantly higher in patients on hemodialysis, patients with a smoking habit, patients with comorbidities, and patients with end-stage renal disease. 7 The factors associated with CKD in diabetics are also important. Their control could go a long way in controlling the risk of progression of CKD in diabetics.…”

Section: Introductionmentioning

confidence: 99%

Chronic kidney disease-prevalence and determinants among type 2 diabetes mellitus patients attending a primary care setting in central Kerala

Soman

Areekal

Varghese

et al. 2018

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: Diabetes mellitus (DM) is one of the most common metabolic diseases characterized by increased blood glucose levels either due to insufficiency/absence of insulin or due to decrease in the insulin sensitivity. The prevalence of chronic kidney disease (CKD) in people with type 2 diabetes is three times higher than in non-diabetic population and majority of people developing end-stage renal diseases (ESRD) have Type 2 DM. The objectives of the study were to find out the prevalence of CKD, mean GFR and associated factors of CKD, in diabetics coming to a primary health care setting in Central Kerala.Methods: A cross-sectional study among all patients attending the NCD clinic of Health Centre, Ettumanoor with confirmed diagnosis of type 2 diabetes mellitus was done between February 2017 and April 2017.Results: The prevalence of CKD among the study population was 45.3%. The proportion of CKD was 34.9% among those with nil urinary protein, 57.1% among those with 1+ urinary protein, 88.9% for those with 2+ and 87.5% among those with 3+ urinary protein. Among those with CKD mean duration of diabetes was 121.92 months against 92.72 months among those without CKD. There was statistically significant difference between RBS values of those with CKD and without CKD (238.49 mg% versus 199.41 mg%). The proportion of CKD was found increase with duration of diabetes 5 years (31.2%), 5-10 years (47.8%), 10-15 years (52.6%) and >15 years (55%).Conclusions: The study showed high prevalence of CKD among diabetics. The duration of diabetes, urinary protein levels and RBS value were found to have strong association with CKD in diabetics.

show abstract

“…In India, HD is expected to cost INR 29,852 per month while peritoneal dialysis will cost INR 28,763 per month [5]. According to another study, sustaining individuals with ESRD costs INR 2,13,144 per year [6].…”

Section: Introductionmentioning

confidence: 99%

Effect of Exercise on Health-Related Quality of Life in Patients with End-Stage Renal Disease

Michael¹,

Fidelis²,

Pakalomattom³

2022

Multidisciplinary Experiences in Renal Replacement Therapy

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is becoming more common around the world. Chronic kidney disease (CKD) is linked to a wide range of other health problems, such as diabetes, hypertension, stroke, and pulmonary illness. Patients with CKD tend to lead sedentary lives for a variety of reasons. Dialysis patients, on the other hand, are much less active than the general population. All of these factors raise the likelihood of future morbidity and mortality, while also lowering the overall quality of life for people who are ill (HRQoL). Regular physical activity (PE) has been shown to increase overall well-being and HRQoL. Here, we discuss several PEs and their effects on CKD patients\' physical fitness, function, and HRQoL, as well as the significance of haematocrit normalisation and the influence on their serum phosphorus levels. We have discussed the advantages of PE for this particular population of individuals as well as the side effects of intradialytic PE. There have also been discussions on factors that contribute to impaired physical function in CKD patients and the impact of PEs on different bodily systems.

show abstract

Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital: Evidence from a Cross-Sectional Study

Abstract: Reimbursement, patient's dialysis status, habits, and comorbidities were found to have a significant effect on the direct cost of treatment.

Cited by 14 publications

References 20 publications

Costs of hospitalization for chronic kidney disease in Guangzhou, China

Costs of hospitalization for chronic kidney disease in Guangzhou, China

Chronic kidney disease-prevalence and determinants among type 2 diabetes mellitus patients attending a primary care setting in central Kerala

Effect of Exercise on Health-Related Quality of Life in Patients with End-Stage Renal Disease

Contact Info

Product

Resources

About